As psychedelics become increasingly decriminalized in various cities and countries, and excitement builds among scientists, physicians, and the general public, it is likely that more individuals with obesity will seek out these emerging treatments. For researchers and clinicians in obesity medicine, it is essential to stay informed about the latest developments in psychedelic therapies and their potential applications in obesity care. This session will provide a balanced, evidence-based overview of the current research on psychedelics, equipping participants with the knowledge to assess their potential role in obesity treatment. CME/CE Expiration Date: 11/5/27 *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
- Provider:Obesity Medicine Association
- Activity Link: https://academy.obesitymedicine.org/node/7625
- Start Date: 2024-11-05 06:00:00
- End Date: 2024-11-05 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Bariatric Surgery